SNN.US Smith & Nephew SNATS Inc

Healthcare Health Care Equipment & Supplies USA Stocks
30.67 USD
Close of Nov 17, 2026
26.07 36.11
Market cap
USD 12.8B
P/E
20.9x
P/B
2.53x
ROE
23.4%
Dividend yield
2.57%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is SNN.US undervalued?

Graham number
Price30.67
Graham value20.03
Premium53.1%

SNN.US trades 53.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Smith & Nephew SNATS Inc fundamental analysis

No fundamental analysis for Smith & Nephew SNATS Inc yet.

Smith & Nephew SNATS Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Smith & Nephew SNATS Inc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used i…

Full company profile